A clinical trial using two independent cohorts showed that circulating GDF15 levels strongly correlated with intrarenal expression of GDF15 and were significantly associated with increased risk of CKD progression and fibrosis [17]. This evidence concerns the gene GDF15 and chronic kidney disease.